Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_51137
http://purl.obolibrary.org/obo/CHEBI_51137
|
|---|---|
| Preferred Name | mianserin |
| Synonyms |
C18H20N2
mianserin
mianserine
2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine
mianserinum
1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine
mianserina
5-methyl-2,5-diazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(15),8(13),9,11,16,18-hexaene
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | mianserin
|
|---|---|
| label | mianserin
|
| DBSynonym |
mianseryna [polish]
mianserine [inn-french]
mianserine
mianserina [inn-spanish]
mianserinum [inn-latin]
|
| ATCCode | N06AX03
|
| Definition | A dibenzoazepine that has formula C18H20N2.
|
| inhibits | |
| type | |
| has role |
See more
See less
|
| InChIKey | InChIKey=UEQUQVLFIPOEMF-UHFFFAOYSA-N
|
| is metabolised by | |
| blocks | |
| Synonym |
C18H20N2
mianserin
mianserine
2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine
mianserinum
1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine
mianserina
5-methyl-2,5-diazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(15),8(13),9,11,16,18-hexaene
See more
See less
|
| xref |
PubChem Compound:4184
ChEBI:51137
PubChem Substance:46508096
Patent:NL6603256
PharmGKB:PA134687937
Beilstein:755346
ChEMBL:100573
ChemSpider:4040
Wikipedia:http://en.wikipedia.org/wiki/Mianserin
CASRN:24219-97-4
IUPHAR:135
Patent:US3534041
DrugBank:DB06148
Guide To Pharmacology:135
See more
See less
|
| CASRN | 24219-97-4
|
| prefixIRI | obo2:CHEBI_51137
|
| SMILES |
CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
CN1CCN2C(C1)c1ccccc1Cc1ccccc21
|
| DBname | mianserin
|
| InChI | InChI=1S/C18H20N2/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19/h2-9,18H,10-13H2,1H3
|
| DBBrand |
tolvan
norval
bolvidon
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |